|
Volumn 24, Issue 9, 2007, Pages 1159-1160
|
Anti TNF alpha therapy - A risk factor for legionella infection [2];Traitement par anti-TNF alpha: Un risque accru de légionellose
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CEFOTAXIME;
ERYTHROMYCIN;
ETANERCEPT;
HEMOGLOBIN;
LEVOFLOXACIN;
METHOTREXATE;
TUMOR NECROSIS FACTOR ALPHA ANTIBODY;
ADULT;
BLOOD CULTURE;
CASE REPORT;
DYSPNEA;
HEMOGLOBIN BLOOD LEVEL;
HUMAN;
LEGIONELLA PNEUMOPHILA;
LEGIONNAIRE DISEASE;
LETTER;
LEUKOCYTE COUNT;
LUNG DISEASE;
LUNG EMBOLISM;
MALE;
MYELOGRAPHY;
PANCYTOPENIA;
POLYMERASE CHAIN REACTION;
RISK FACTOR;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
HUMANS;
IMMUNOGLOBULIN G;
LEGIONELLOSIS;
MALE;
METHOTREXATE;
MIDDLE AGED;
OPPORTUNISTIC INFECTIONS;
RECEPTORS, TUMOR NECROSIS FACTOR;
RISK FACTORS;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 37349011274
PISSN: 07618425
EISSN: None
Source Type: Journal
DOI: 10.1016/S0761-8425(07)74271-7 Document Type: Letter |
Times cited : (5)
|
References (7)
|